Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Clonal Hematopoiesis of Indeterminate Potential clinical trials
3 of 3 indexed Clonal Hematopoiesis of Indeterminate Potential trials are currently recruiting.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 3 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Clonal Hematopoiesis of Indeterminate Potential: 3 US clinical trials tracked, 3 recruiting.
Clonal Hematopoiesis of Indeterminate Potential is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. The most active sponsor is National Heart, Lung, and Blood Institute (NHLBI), running 1 of these trials.
Enrollment posture brief
Registry condition clonal-hematopoiesis-of-indeterminate-potential
OPEN 3 | RECR 100% | LATE 0 | EARLY 0 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Clonal Hematopoiesis of Indeterminate Potential lists 3 open slots (100% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Clonal Hematopoiesis of Indeterminate Potential on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Clonal Hematopoiesis of Indeterminate Potential is recruiting above its size-band peers.
3 of 3 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
Mayo Clinic
NCT02958462
CHIP/CCUS Natural History Protocol
National Heart, Lung, and Blood Institute (NHLBI)
NCT04102423
Pre-malignant States to Hematologic Malignancies in Firefighters
Wake Forest University Health Sciences
NCT06870760
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Clonal Hematopoiesis of Indeterminate Potential records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Clonal Hematopoiesis of Indeterminate Potential trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Clonal Hematopoiesis of Indeterminate Potential page
3 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Clonal Hematopoiesis of Indeterminate Potential trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Heart, Lung, and Blood Institute (NHLBI) sponsors the most Clonal Hematopoiesis of Indeterminate Potential trials on record, review their full trial history before evaluating a specific study. See National Heart, Lung, and Blood Institute (NHLBI)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Clonal Hematopoiesis of Indeterminate Potential condition card totals 3 registered trials; most-linked intervention Clonal hematopoiesis (CHIP); top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.